Mail

UK markets closed

FTSE 100
8,139.83
+60.97(+0.75%)
FTSE 250
19,824.16
+222.18(+1.13%)
AIM
755.28
+2.16(+0.29%)
GBP/EUR
1.1679
+0.0022(+0.19%)
GBP/USD
1.2494
-0.0017(-0.13%)
Bitcoin GBP
50,556.62
+700.92(+1.41%)

'We sold £1.5m of product sold in first week'

Lyma founder on rise of her wellness company

Bone Biologics Corporation (BBLG)

NasdaqCM - NasdaqCM Delayed price. Currency in USD

Add to watchlist

1.5300

-0.0200

(-1.29%)

At close: 04:00PM EDT

1.6100

+0.08

(+5.23%)

After hours:

06:48PM EDT

Currency in USD

Valuation measures⁴

Market cap (intra-day)	1.35M
Enterprise value	-1.68M
Trailing P/E	N/A
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	N/A
Price/book (mrq)	0.46
Enterprise value/revenue	N/A
Enterprise value/EBITDA	0.18

Trading information

Stock price history

Beta (5Y monthly)	0.58
52-week change ³	-97.38%
S&P500 52-week change ³	22.36%
52-week high ³	72.0000
52-week low ³	1.4600
50-day moving average ³	2.2534
200-day moving average ³	4.6634

Share statistics

Avg vol (3-month) ³	82.15k
Avg vol (10-day) ³	40.28k
Shares outstanding ⁵	879.18k
Implied shares outstanding ⁶	879.18k
Float ⁸	480.93k
% held by insiders ¹	8.15%
% held by institutions ¹	1.26%
Shares short (15 Apr 2024) ⁴	12.99k
Short ratio (15 Apr 2024) ⁴	0.45
Short % of float (15 Apr 2024) ⁴	1.53%
Short % of shares outstanding (15 Apr 2024) ⁴	1.48%
Shares short (prior month 15 Mar 2024) ⁴	31.09k

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	24 Jul 2018
Ex-dividend date ⁴	N/A
Last split factor ²	1:8
Last split date ³	20 Dec 2023

Financial highlights

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Dec 2023

Profitability

Profit margin	0.00%
Operating margin (ttm)	0.00%

Management effectiveness

Return on assets (ttm)	-96.34%
Return on equity (ttm)	-202.15%

Income statement

Revenue (ttm)	N/A
Revenue per share (ttm)	N/A
Quarterly revenue growth (yoy)	N/A
Gross profit (ttm)	N/A
EBITDA	N/A
Net income avi to common (ttm)	-8.95M
Diluted EPS (ttm)	-34.0100
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	3.03M
Total cash per share (mrq)	5.66
Total debt (mrq)	N/A
Total debt/equity (mrq)	N/A
Current ratio (mrq)	4.50
Book value per share (mrq)	5.44

Cash flow statement

Operating cash flow (ttm)	-9.56M
Levered free cash flow (ttm)	-7.21M